Nathaniel Lipkus is a partner in the Intellectual Property Department of Osler, Hoskin & Harcourt LLP. His litigation practice focuses on contentious legal issues confronting innovation-intensive industries, with an emphasis on patent and regulatory issues facing pharmaceutical and biotechnology companies.

Articles by this author

NAFTA and a made-in-Canada IP framework

Nearly a quarter-century ago, the United States, Canada and Mexico concluded the North American Free Trade Agreement (NAFTA), implemented in 1994, and it included the first intellectual property (IP) chapter in an international trade agreement, …

Read More